Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by interleukin-6 blockade. - Baruch EN; Nagarajan P; Gleber-Netto FO; Rao X; Xie T; Akhter S; Adewale A; Shajedul I; Mattson BJ; Ferrarotto R; Wong MK; Davies MA; et al. (Research square, 2023)